Merck (MRK) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $82.0 billion.
- Merck's Non-Current Assets rose 624.33% to $82.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $320.4 billion, marking a year-over-year increase of 661.65%. This contributed to the annual value of $78.3 billion for FY2024, which is 512.3% up from last year.
- As of Q3 2025, Merck's Non-Current Assets stood at $82.0 billion, which was up 624.33% from $80.5 billion recorded in Q2 2025.
- Over the past 5 years, Merck's Non-Current Assets peaked at $82.0 billion during Q3 2025, and registered a low of $62.0 billion during Q2 2021.
- Moreover, its 5-year median value for Non-Current Assets was $74.5 billion (2023), whereas its average is $74.0 billion.
- Over the last 5 years, Merck's Non-Current Assets had its largest YoY gain of 2088.9% in 2022, and its largest YoY loss of 263.83% in 2022.
- Quarter analysis of 5 years shows Merck's Non-Current Assets stood at $75.4 billion in 2021, then dropped by 2.64% to $73.4 billion in 2022, then grew by 1.46% to $74.5 billion in 2023, then grew by 5.12% to $78.3 billion in 2024, then increased by 4.68% to $82.0 billion in 2025.
- Its Non-Current Assets was $82.0 billion in Q3 2025, compared to $80.5 billion in Q2 2025 and $79.6 billion in Q1 2025.